New depression drug shows promise in early trial

NCT ID NCT06391593

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested an experimental drug called ALTO-203 in 69 adults with moderate major depressive disorder who also had anhedonia (loss of interest or pleasure). Participants received either a low dose, a higher dose, or a placebo, and reported their mood and alertness. The goal was to see if the drug improves mood and is safe over a 28-day period.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anhedonia major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Site 4005

    Orlando, Florida, 32801, United States

  • Site 4007

    Clinton, Utah, 84015, United States

  • Site 4022

    Marlton, New Jersey, 08053, United States

  • Site 4023

    Torrance, California, 90504, United States

  • Site 4031

    Atlanta, Georgia, 30030, United States

  • Site 4033

    Bellevue, Washington, 98007, United States

  • Site 4036

    Las Vegas, Nevada, 89121, United States

  • Site 4040

    Austin, Texas, 78737, United States

  • Site 4054

    Pikesville, Maryland, 21208, United States

  • Site 4058

    Tucson, Arizona, 85704, United States

  • Site 4059

    Clermont, Florida, 34711, United States

  • Site 4072

    Houston, Texas, 77081, United States

  • Site 4075

    Westlake, Ohio, 44145, United States

  • Site 4082

    Oceanside, California, 92056, United States

  • Site 4134

    Princeton, New Jersey, 08540, United States